By Pascal Descargues, Ph.D.
In 2006 I had just finished my Ph.D. in human pathophysiology, and I was working in a lab in Toulouse, France, studying gene functions in mice. Starting a biotech company was not my focus at that particular time, but it was my work and research in this lab that sparked Genoskin’s birth.
I was working on a rare inherited genetic disorder that affects the skin, hair, and immune system, known as Netherton syndrome. Babies born with the syndrome are afflicted with red scaly skin and, in severe cases, are susceptible to infection, which can be life-threatening.